Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to monitor the gastrointestinal transport of eroding gel matrix placebo tablets in healthy male volunteers under fasting and fed conditions. The method which is used is an imaging technique.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Basic Science


Related Conditions & MeSH terms


NCT number NCT01224587
Study type Interventional
Source AstraZeneca
Contact
Status Completed
Phase Phase 1
Start date October 2010
Completion date November 2010

See also
  Status Clinical Trial Phase
Completed NCT04501640 - A Study to Investigate the Effect of Food With Mirabegron in Healthy Chinese Participants Phase 4
Withdrawn NCT02560363 - A Study to Compare the Pharmacokinetics of Different Formulations of AZD9977 and the Influence of Food in Healthy Male Subjects Phase 1
Completed NCT02017236 - A Food Effect Phase I Study of the Volitinib in Healthy Subjects Phase 1
Completed NCT03150498 - A Food Effects Study and Optional Multi Dose Study to Assess PK of BTD-001 Phase 1
Completed NCT01686217 - A Phase I Study to Compare 3 Different Strengths of an Extended Release Formulation of ASP015K to an Immediate Release Formulation of ASP015K Phase 1
Completed NCT01322464 - Study to Assess Food Effect on Sativex Bioavailability Phase 1
Completed NCT03885778 - A Food Effect Study of Besifovir in Healthy Subjects Phase 4
Completed NCT05690932 - A Formulation Bridging and Food Effect Study of PBI-200 in Healthy Volunteers Phase 1
Completed NCT05187169 - Food Effect of VS-6766 in Healthy Adult Subjects Phase 1
Completed NCT05217732 - Study to Assess the Safety, Tolerability and Pharmacokinetics of ZX-7101A and the Food Effect in Healthy Volunteers Phase 1